119th Congress
H.R. 1672
Maintaining Investments in New Innovation Act
- Introduced
- In committee
- Passed House
- Passed Senate
- To President
- Became law
- Sponsor
- Donald G. Davis(D-NC)
- Introduced
- Feb 27, 2025
- Policy area
- Health
- Committees
- House Committee on Energy and Commerce; House Committee on Ways and Means
- Official text
- Introduced in House · Congress.gov page
Cosponsors (51)
Original cosponsors (13)
- Aaron Bean (R-FL)
- Beth Van Duyne (R-TX)
- Blake D. Moore (R-UT)
- Claudia Tenney (R-NY)
- Dan Crenshaw (R-TX)
- John Joyce (R-PA)
- Joseph D. Morelle (D-NY)
- Josh Gottheimer (D-NJ)
- Mariannette Miller-Meeks (R-IA)
- Richard Hudson (R-NC)
- Rick W. Allen (R-GA)
- Rudy Yakym III (R-IN)
- Scott H. Peters (D-CA)
Added later (38)
- Neal P. Dunn (R-FL) · Mar 27, 2025
- Kevin Hern (R-OK) · Apr 9, 2025
- Mike Carey (R-OH) · Apr 10, 2025
- Jefferson Shreve (R-IN) · May 9, 2025
- August Pfluger (R-TX) · May 13, 2025
- Pete Sessions (R-TX) · Jun 4, 2025
- Addison P. McDowell (R-NC) · Jun 10, 2025
- Mike Kelly (R-PA) · Sep 2, 2025
- Charles J. "Chuck" Fleischmann (R-TN) · Sep 17, 2025
- Brittany Pettersen (D-CO) · Sep 30, 2025
- Daniel Meuser (R-PA) · Sep 30, 2025
- Nicole Malliotakis (R-NY) · Sep 30, 2025
- Troy Balderson (R-OH) · Oct 3, 2025
- Tim Moore (R-NC) · Oct 17, 2025
- Chuck Edwards (R-NC) · Oct 31, 2025
- John R. Moolenaar (R-MI) · Oct 31, 2025
- Ken Calvert (R-CA) · Oct 31, 2025
- Randy K. Weber, Sr. (R-TX) · Oct 31, 2025
- Vince Fong (R-CA) · Nov 4, 2025
- Brian Jack (R-GA) · Nov 10, 2025
- Nathaniel Moran (R-TX) · Nov 17, 2025
- Laurel M. Lee (R-FL) · Nov 21, 2025
- Mike Haridopolos (R-FL) · Nov 21, 2025
- Thomas H. Kean, Jr. (R-NJ) · Nov 21, 2025
- Ashley Hinson (R-IA) · Dec 4, 2025
- Kevin Mullin (D-CA) · Dec 9, 2025
- Michael Lawler (R-NY) · Jan 13, 2026
- Andy Barr (R-KY) · Mar 20, 2026
- Gus M. Bilirakis (R-FL) · Apr 15, 2026
- Adrian Smith (R-NE) · Jun 18, 2026
- Lloyd Smucker (R-PA) · Jun 18, 2026
- Nicholas A. Langworthy (R-NY) · Jun 18, 2026
- Gabe Evans (R-CO) · Jun 25, 2026
- Earl L. "Buddy" Carter (R-GA) · Aug 10, 2026
- Jared Moskowitz (D-FL) · Aug 10, 2026
- Brian K. Fitzpatrick (R-PA) · Aug 27, 2026
- Vicente Gonzalez (D-TX) · Sep 4, 2026
- Michael A. Rulli (R-OH) · Sep 24, 2026
Summary
Summary by the Congressional Research Service· describes the “Introduced in House” version
Maintaining Investments in New Innovation Act
This bill requires drug products with genetically targeted technology to have had market approval for at least 11 years in order to qualify for the Medicare Drug Price Negotiation Program. (The program requires the Centers for Medicare & Medicaid Services to negotiate the prices of certain prescription drugs under Medicare beginning in 2026. Among other requirements, drugs must have had market approval for at least 7 years (for drug products) or 11 years (for biologics) to qualify for negotiation.)
Roll-call votes
No recorded votes on this bill.
Actions
- Feb 27, 2025 · House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. - Feb 27, 2025
Introduced in House